A recent New York Times article highlighted the potentially under-reported side effect of Paradoxical Adipose Hyperplasia (PAH) associated with CoolSculpting treatments. This revelation is raising concerns among those considering non-invasive fat reduction options. So. we want to set the record straight and explain how Cryoskin offers a safer alternative without this risk of PAH due to its unique, suction-free approach.
What is PAH?
Paradoxical Adipose Hyperplasia (PAH) is a rare but distressing complication that can occur following CoolSculpting treatments. It involves the unexpected growth of fat cells in the treated area, resulting in a visibly enlarged and hardened mass.
Cryoskin is a non-invasive fat reduction treatment that offers a safer alternative to CoolSculpting, without the risk of PAH.
Cryoskin uses a handheld device that glides over the skin’s surface, delivering precise and controlled cooling to the targeted fat cells. This suction-free approach differentiates Cryoskin from CoolSculpting and significantly reduces the likelihood of PAH.
Key reasons why Cryoskin doesn’t have the same PAH risks as CoolSculpting:
- No Suction: By eliminating suction from the treatment process, Cryoskin minimizes potential stress and trauma to the treated area, reducing the likelihood of PAH development. This gentle treatment allows for a more comfortable experience without compromising results.
- Controlled Application: Cryoskin’s handheld device allows for better control and customization of the treatment, ensuring a more even and consistent application of cooling temperatures. This reduces the risk of overcooling or uneven treatment, which could potentially lead to PAH.
- Gradual Cooling: Cryoskin gradually lowers the temperature in the treated area, ensuring a more controlled and gentle cooling process. This gradual approach helps to minimize the risk of sudden temperature changes that could contribute to PAH. (source: artemis.co)
